Soleno Therapeutics Stock Price History
| SLNO Stock | USD 52.71 3.13 5.61% |
Below is the normalized historical share price chart for Soleno Therapeutics extending back to November 13, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Soleno Therapeutics stands at 52.71, as last reported on the 30th of November, with the highest price reaching 55.27 and the lowest price hitting 51.39 during the day.
If you're considering investing in Soleno Stock, it is important to understand the factors that can impact its price. Soleno Therapeutics appears to be very steady, given 3 months investment horizon. Soleno Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0723, which indicates the firm had a 0.0723% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Soleno Therapeutics, which you can use to evaluate the volatility of the company. Please review Soleno Therapeutics' Semi Deviation of 2.5, coefficient of variation of 1389.11, and Risk Adjusted Performance of 0.0625 to confirm if our risk estimates are consistent with your expectations.
At this time, Soleno Therapeutics' Stock Based Compensation is very stable compared to the past year. . At this time, Soleno Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 30th of November 2024, Price Earnings To Growth Ratio is likely to grow to 7.21, though Price To Sales Ratio is likely to grow to (0.01). Soleno Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of November 2014 | 200 Day MA 47.1437 | 50 Day MA 53.4154 | Beta (1.44) |
Soleno |
Sharpe Ratio = 0.0723
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SLNO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.99 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Soleno Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Soleno Therapeutics by adding it to a well-diversified portfolio.
Price Book 8.5861 | Book Value 6.45 | Enterprise Value 2 B | Enterprise Value Ebitda 0.0233 | Shares Float 27.5 M |
Soleno Therapeutics Stock Price History Chart
There are several ways to analyze Soleno Stock price data. The simplest method is using a basic Soleno candlestick price chart, which shows Soleno Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 59.18 |
| Lowest Price | September 24, 2024 | 46.88 |
Soleno Therapeutics November 30, 2024 Stock Price Synopsis
Various analyses of Soleno Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Soleno Stock. It can be used to describe the percentage change in the price of Soleno Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Soleno Stock.| Soleno Therapeutics Price Rate Of Daily Change | 0.94 | |
| Soleno Therapeutics Accumulation Distribution | 86,106 | |
| Soleno Therapeutics Price Daily Balance Of Power | (0.81) | |
| Soleno Therapeutics Price Action Indicator | (2.19) |
Soleno Therapeutics November 30, 2024 Stock Price Analysis
Soleno Stock Price History Data
The price series of Soleno Therapeutics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 12.61 with a coefficient of variation of 6.23. The price distribution for the period has arithmetic mean of 52.58. The median price for the last 90 days is 52.84. The company completed stock split (1:15) on . Soleno Therapeutics had dividends distributed to its stock-holders on 2017-10-06.| Open | High | Low | Close | Volume | ||
| 11/29/2024 | 55.02 | 55.27 | 51.39 | 52.71 | 1,226,573 | |
| 11/27/2024 | 58.51 | 58.88 | 55.15 | 55.84 | 543,017 | |
| 11/26/2024 | 53.62 | 59.32 | 53.25 | 58.34 | 1,528,640 | |
| 11/25/2024 | 58.96 | 60.92 | 57.02 | 57.22 | 921,342 | |
| 11/22/2024 | 55.00 | 57.94 | 54.64 | 57.78 | 595,169 | |
| 11/21/2024 | 55.00 | 55.97 | 53.40 | 54.63 | 333,890 | |
| 11/20/2024 | 51.78 | 55.51 | 51.78 | 54.83 | 673,316 | |
| 11/19/2024 | 51.45 | 52.56 | 51.08 | 51.79 | 464,031 | |
| 11/18/2024 | 51.80 | 53.03 | 50.69 | 51.64 | 550,626 | |
| 11/15/2024 | 54.24 | 54.46 | 51.37 | 51.80 | 656,758 | |
| 11/14/2024 | 55.49 | 56.01 | 53.62 | 54.08 | 468,408 | |
| 11/13/2024 | 57.33 | 58.99 | 55.56 | 55.68 | 403,922 | |
| 11/12/2024 | 58.85 | 59.45 | 56.85 | 57.31 | 430,955 | |
| 11/11/2024 | 58.40 | 59.75 | 57.73 | 59.18 | 535,611 | |
| 11/08/2024 | 56.64 | 58.36 | 56.34 | 57.05 | 513,190 | |
| 11/07/2024 | 55.62 | 59.36 | 55.62 | 57.11 | 698,646 | |
| 11/06/2024 | 58.00 | 58.68 | 56.30 | 56.86 | 753,536 | |
| 11/05/2024 | 56.38 | 56.73 | 55.64 | 56.39 | 399,787 | |
| 11/04/2024 | 56.01 | 56.50 | 54.82 | 56.14 | 311,484 | |
| 11/01/2024 | 56.00 | 56.50 | 55.30 | 55.86 | 362,413 | |
| 10/31/2024 | 55.79 | 56.26 | 54.10 | 55.06 | 377,762 | |
| 10/30/2024 | 56.03 | 56.47 | 55.22 | 55.72 | 485,955 | |
| 10/29/2024 | 54.97 | 56.51 | 54.94 | 56.29 | 564,239 | |
| 10/28/2024 | 56.29 | 57.28 | 54.96 | 55.31 | 723,630 | |
| 10/25/2024 | 53.69 | 56.07 | 53.54 | 54.92 | 553,174 | |
| 10/24/2024 | 53.02 | 54.30 | 51.92 | 53.03 | 594,923 | |
| 10/23/2024 | 53.26 | 53.77 | 51.97 | 52.70 | 478,097 | |
| 10/22/2024 | 53.14 | 54.97 | 53.14 | 53.64 | 465,015 | |
| 10/21/2024 | 54.06 | 54.16 | 53.02 | 53.75 | 540,618 | |
| 10/18/2024 | 53.91 | 54.86 | 53.34 | 54.16 | 692,283 | |
| 10/17/2024 | 53.94 | 54.44 | 53.00 | 53.50 | 699,187 | |
| 10/16/2024 | 54.46 | 55.00 | 53.95 | 54.50 | 585,381 | |
| 10/15/2024 | 53.48 | 55.02 | 53.20 | 54.15 | 540,111 | |
| 10/14/2024 | 54.52 | 55.35 | 53.38 | 53.86 | 467,958 | |
| 10/11/2024 | 51.23 | 54.92 | 50.85 | 54.75 | 1,305,653 | |
| 10/10/2024 | 50.48 | 51.81 | 49.50 | 50.80 | 795,442 | |
| 10/09/2024 | 52.00 | 52.00 | 50.25 | 51.08 | 1,159,927 | |
| 10/08/2024 | 56.00 | 56.81 | 50.36 | 51.97 | 4,532,397 | |
| 10/07/2024 | 49.34 | 49.34 | 47.43 | 47.63 | 292,031 | |
| 10/04/2024 | 48.89 | 50.28 | 48.89 | 49.63 | 584,379 | |
| 10/03/2024 | 49.02 | 50.01 | 48.77 | 48.95 | 248,573 | |
| 10/02/2024 | 49.43 | 50.60 | 49.31 | 49.68 | 365,846 | |
| 10/01/2024 | 50.49 | 50.49 | 48.86 | 49.63 | 525,899 | |
| 09/30/2024 | 49.28 | 51.08 | 48.54 | 50.49 | 770,104 | |
| 09/27/2024 | 48.93 | 50.64 | 48.93 | 49.13 | 349,429 | |
| 09/26/2024 | 49.25 | 50.26 | 48.55 | 48.77 | 330,812 | |
| 09/25/2024 | 47.12 | 49.74 | 46.85 | 48.78 | 470,240 | |
| 09/24/2024 | 48.88 | 48.89 | 46.31 | 46.88 | 764,821 | |
| 09/23/2024 | 51.65 | 51.82 | 48.09 | 48.14 | 611,599 | |
| 09/20/2024 | 52.73 | 52.85 | 49.69 | 51.61 | 979,955 | |
| 09/19/2024 | 55.00 | 55.56 | 52.61 | 52.73 | 456,946 | |
| 09/18/2024 | 52.68 | 54.50 | 52.29 | 53.55 | 411,981 | |
| 09/17/2024 | 53.41 | 54.37 | 52.03 | 52.92 | 446,732 | |
| 09/16/2024 | 53.05 | 53.15 | 51.50 | 52.79 | 277,479 | |
| 09/13/2024 | 49.73 | 54.09 | 49.70 | 52.84 | 995,911 | |
| 09/12/2024 | 48.54 | 49.97 | 48.38 | 49.61 | 336,917 | |
| 09/11/2024 | 49.29 | 50.52 | 48.57 | 48.58 | 373,487 | |
| 09/10/2024 | 48.56 | 50.25 | 47.91 | 49.43 | 366,820 | |
| 09/09/2024 | 48.96 | 50.01 | 48.05 | 48.75 | 423,042 | |
| 09/06/2024 | 49.92 | 50.33 | 47.86 | 48.54 | 224,625 | |
| 09/05/2024 | 49.26 | 50.81 | 49.18 | 49.92 | 265,412 |
About Soleno Therapeutics Stock history
Soleno Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Soleno is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Soleno Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Soleno Therapeutics stock prices may prove useful in developing a viable investing in Soleno Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 16.5 M | 17.3 M | |
| Net Loss | -21.7 M | -22.7 M |
Soleno Therapeutics Quarterly Net Working Capital |
|
Soleno Therapeutics Stock Technical Analysis
Soleno Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Soleno Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Soleno Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Soleno Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Soleno to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0625 | |||
| Jensen Alpha | 0.0689 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0305 | |||
| Treynor Ratio | 0.191 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soleno Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Return On Assets (0.48) | Return On Equity (0.91) |
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.